WallStreetZenWallStreetZen

NASDAQ: PCVX
Vaxcyte Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Vaxcyte earnings were -$946.5M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest PCVX earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$320.6M, up 30.1% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, PCVX reported annual earnings of -$766.6M, with 65.2% growth.

PCVX earnings history

Current Revenue
$0.0
Current Earnings
-$946.5M
Current Profit Margin
0%

PCVX Return on Equity

Current Company
-32.5%
Current Industry
-143.8%
Current Market
5.2%
PCVX's Return on Equity (-32.5%)... subscribe to Premium to read more.
High Return on Equity Performance

PCVX Return on Assets

Current Company
-29.5%
Current Industry
-10.8%
PCVX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when PCVX announces earnings.

PCVX Return on Capital Employed

Current Company
-30.47%
Current Industry
-6.9%
PCVX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

PCVX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
PCVX-$920.69M-$946.53MN/A-$6.88
NUVL-$449.48M-$450.07MN/A-$6.06
TECH$255.98M$109.56M-9.99%$0.71
HALO$623.82M$348.84M+19.79%$2.96
IBRX-$719.86M-$854.53MN/A-$0.85
View Top Biotech Stocks

Vaxcyte Earnings Reports & History FAQ

What were Vaxcyte's earnings last quarter?

Vaxcyte (NASDAQ: PCVX) reported Q1 2026 earnings per share (EPS) of -$2.30, up 121.15% year over year. Total PCVX earnings for the quarter were -$320.62 million. In the same quarter last year, Vaxcyte's earnings per share (EPS) was -$1.04.

If you're new to stock investing, here's how to buy Vaxcyte stock.

Is Vaxcyte profitable or losing money?

As of the last Vaxcyte earnings report, Vaxcyte is currently losing money. Vaxcyte's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$946.53 million, a 85.73% increase year over year.

What was PCVX's earnings growth in the past year?

As of Vaxcyte's earnings date in Q2 2026, Vaxcyte's earnings has grown year over year. PCVX earnings in the past year totalled -$946.53 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.